Kalaris Therapeutics (KLRS) announced the appointment of Matthew Gall, MBA, as Chief Financial Officer. Gall most recently served as Chief Financial Officer of iTeos Therapeutics.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KLRS: